Illumina to acquire NextBio

|By:, SA News Editor

Illumina (ILMN -0.7%) is set to acquire NextBio, which has the capability to "aggregate and analyze large quantities of phenotypic and genomic data for research and clinical applications."

ILMN says the deal will allow it to "offer customers enterprise level bioinformatics solutions that accelerate the discovery of new associations between the human genome and disease, and ultimately, enable the application of those discoveries within healthcare." (PR)

ILMN also affirms its 2013 guidance for good measure.